Compiled by Sulpicio G. Soriano, M.D.
Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts

1. Abe K: Vasodilators during cerebral aneurysm surgery. Can J Anaesth 40:775-790, 1993.

2. Adams HP, Jr, Kassell NF, Torner JC, Haley EC: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 37:1586-1591, 1987.

+3. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chow SN, Kelley DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA Transow CR: Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-624, 1983.

4. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr: Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 18:365-372, 1987.

*5. Barker FG, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405-414, 1996.

6. Dalbasti T, Karabiyikoglu M, Ozdamar N, Oktar N, Cagli S.Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg 95:44-50, 2001.

7. Dernbach PD, Little JR, Jones SC, Ebrahim ZY: Altered cerebral autoregulation and CO2 reactivity after aneurysmal subarachnoid hemorrhage. Neurosurgery 22:822-826, 1988.

8. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 49:593-605, 2001.

+9. Eskridge JM, Newell DW, Winn HR: Endovascular treatment of vasospasm. Neurosurg Clin North America 5:437-447, 1994.

10. Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, Duong H, Pile-Spellman J. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience.AJNR Am J Neuroradiol.23:1284-90, 2002.

11. Firlik AD, Kaufmann AM, Jungreis CA, Yonas H: Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 86:830-839, 1997.

*12. Findlay JM, Kassell NF, Weir BKA, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg GK, West M, Winn HR, Ferguson G: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-176, 1995.

*+13. Guy J, McGrath BJ, Borel CO, Friedman AH, Warner DS: Perioperative management of aneurysmal subarachnoid hemorrhage: Part 1. Operative management. Anesth Analg 81:1060-1072, 1995.

*14. Haley EC, Kassell NF, Torner JC: The International Cooperative Study on the timing of aneurysm surgery. The North American experience. Stroke 23:205-214, 1992.

*15. Haley EC, Kassell NF, Torner JC: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78:537-547, 1993.

*16. Haley EC, Kassell NF: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmalsubarachnoid hemorrhage: a cooperative study in North American. J Neurosurg 86:467-474, 1997.

*17. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343, 1982.

*18. Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL: The International Cooperative Study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73:18-32, 1990.

*19. Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP: The International Cooperative Study on the timing of aneurysm surgery. Part 2: Surgical results. J Neurosurg 73:37-47, 1990.

*+20. Kassell NF, Sasaki T, Colohan AR, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985.

*21. Liszczak TM, Varsos VG, Black PM, Kistler JP, Zervas NT: Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 58:18-26, 1983.

22. Luo Z, Harada T, London S, Gajdusek C, Mayberg MR: Antioxidant and iron-chelating agents in cerebral vasospasm. Neurosurgery 37:1154-1158, 1995.

+23. MacDonald RL, Wallace MC, Coyne TJ: The effect of surgery on the severity of vasospasm. J Neurosurg 80:433-439, 1994.

+24. MacDonald RL, Weir BK: Cerebral vasospasm and free radicals. Free Rad Biol Med 16:633-663, 1994.

+25. MacDonald RL, Weir BK: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.

*26. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. 25:2315-2328, 1994.

27. McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase.Stroke. 2002 Sep;33(9):2317-23.

+28. McGrath BJ, Guy J, Borel CO, Friedman AH, Warner DS: Perioperative management of aneurysmal subarachnoid hemorrhage: Part 2. Postoperative management. Anesth Analg 81:1295-1302, 1995.

29. Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, Sciacca RR, Solomon RA, Mayer SA, Connolly ES Jr. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 97:537-41, 2002.

30. Mori K, Arai H, Nakajima K, Tajima A, Maeda M: Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 26:1620-1626, 1995.

31. Nishizawa S, Yamamoto S, Yokoyama T, Ryu H, Uemura K: Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm. Stroke 26:1916-1920, 1995.

32. Ohkuma H, Suzuki S, Kimura M, Sobata E: Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22:854-859, 1991.

33. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, Oldfield EH Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 87:287-93, 1997.

34. Powers WJ, Grubb RL, Baker RP, Mintum MA, Raichle ME: Regional cerebral blood flow and metabolism in reversible ischemia due to vasospasm. Determination by positron emission tomography. J Neurosurg 62:539-546, 1994.

35. Pyne GJ, Cadoux-Hudson TA, Clark JF The presence of an extractable substance in the CSF of humans with cerebral vasospasm after subarachnoid haemorrhage that correlates with phosphatase inhibition. Biochim Biophys Acta 1474:283-290, 2000.

36. Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 50:1006-13, 2002.

37. Shimoda M, Oda S, Tsugane R, Sato O:Intracranial complications of hypervolemic therapy in patients with delayed ischemic deficit attributed to vasospasm J Neurosurg 78:423-429, 1993.

38. Smith RR, Clower BR, Grotendorst GM, Yabuno N, Cruse JM: Arterial wall changes in early human vasospasm. Neurosurgery 16:171-176, 1985.

39. Suarez JI, Qureshi AI, Yahia AB, Parekh PD, Tamargo RJ, Williams MA, Ulatowski JA, Hanley DF, Razumovsky AY. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution.
Crit Care Med. 30:1348-55, 2002.

40. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96-100, 1992.

+41. Tani E, Molecular mechanisms involved in development of cerebral vasospasm (review), Neurosurg. Focus 12 (3) 2002.

42. Topcuoglu MA, Pryor JC, Ogilvy CS, Kistler JP. Cerebral vasospasm following subarachnoid hemorrhage.Curr Treat Options Cardiovasc Med. 2002 Oct;4(5):373-384.

VoldbyB, Enevoldsen EM, Jensen FT: Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 62:59-67, 1985.

43. Yakubu MA, Leffler CW Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC. Am J Physiol 276:C300-5, 1999.